188 related articles for article (PubMed ID: 1695911)
1. Immunologic defects in leprosy patients. II. Interleukin 1, interleukin 2, and interferon production in leprosy patients.
Makonkawkeyoon S; Kasinrerk W; Supajatura V; Hirunpetcharat C; Vithayasai V
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):311-8. PubMed ID: 1695911
[TBL] [Abstract][Full Text] [Related]
2. Immunologic defects in leprosy patients. I. Evidence of immune aberration of suppressor-T lymphocytes in lepromatous leprosy.
Makonkawkeyoon S; Kasinrerk W; Dettrairat S; Vithayasai V
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):302-10. PubMed ID: 2142947
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte superoxide dismutase, catalase activities and hydrogen peroxide induced lipid peroxidation in leprosy.
Prasad CV; Kodliwadmath MV; Kodliwadmath GB
Lepr Rev; 2007 Dec; 78(4):391-7. PubMed ID: 18309714
[TBL] [Abstract][Full Text] [Related]
4. Natural killer-cell-mediated and antibody-dependent cellular cytotoxicity in leprosy.
Chiplunkar SV; Deshmukh MV; Samson PD; Butlin R; Bhatki WS; Chulawalla RG; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):334-41. PubMed ID: 2376683
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
6. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
[TBL] [Abstract][Full Text] [Related]
7. Study of serum lipids in leprosy.
Gupta A; Koranne RV; Kaul N
Indian J Dermatol Venereol Leprol; 2002; 68(5):262-6. PubMed ID: 17656962
[TBL] [Abstract][Full Text] [Related]
8. Pituitary-gonadal hormones and interleukin patterns in leprosy.
Leal AM; Magalhães PK; Souza CS; Foss NT
Trop Med Int Health; 2006 Sep; 11(9):1416-21. PubMed ID: 16930264
[TBL] [Abstract][Full Text] [Related]
9. Erythrocyte glutathione peroxidase, glutathione reductase activities and blood glutathione content in leprosy.
Prasad CV; Kodliwadmath MV; Kodliwadmath GB
J Infect; 2008 Jun; 56(6):469-73. PubMed ID: 18440071
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte arginase activity in leprosy--a preliminary report.
Babu CS; Kannan KB; Bharadwaj VP; Katoch VM
Indian J Med Res; 1990 May; 91():193-6. PubMed ID: 2397940
[TBL] [Abstract][Full Text] [Related]
11. Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy.
Goulart IM; Mineo JR; Foss NT
Clin Exp Immunol; 2000 Dec; 122(3):330-4. PubMed ID: 11122237
[TBL] [Abstract][Full Text] [Related]
12. Enzyme immunoassay of phagocytosis stimulating tetrapeptide "tuftsin" in normal and leprosy sera.
Kaur J; Khare S; Bhutani LK; Rao DN
Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):576-81. PubMed ID: 1802940
[TBL] [Abstract][Full Text] [Related]
13. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
[TBL] [Abstract][Full Text] [Related]
14. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
[TBL] [Abstract][Full Text] [Related]
15. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
[TBL] [Abstract][Full Text] [Related]
16. Mitogen induced proliferation and cytokine production by lymphocytes from leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Acta Leprol; 1991; 7(5):397-402. PubMed ID: 1805495
[TBL] [Abstract][Full Text] [Related]
17. Detection of antibodies to 35 kD determinant of M. leprae in urine and serum of leprosy patients.
Patil S; Dwivedi P; Kiran K; Singh K; Sengupta U
Acta Leprol; 1990; 7(2):139-43. PubMed ID: 1699385
[TBL] [Abstract][Full Text] [Related]
18. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
19. Production of host-protective (IFN-gamma), host-impairing (IL-10, IL-13) and inflammatory (TNF-alpha) cytokines by PBMC from leprosy patients stimulated with mycobacterial antigens.
Machado P; Abrams J; Santos S; Brennan P; Barral A; Barral-Netto M
Eur J Dermatol; 1998 Mar; 8(2):98-103. PubMed ID: 9649657
[TBL] [Abstract][Full Text] [Related]
20. Activation of complement by circulating immune complexes isolated from leprosy patients.
Tyagi P; Ramanathan VD; Girdhar BK; Katoch K; Bhatia AS; Sengupta U
Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):31-8. PubMed ID: 2319186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
